| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.34 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |